Equip EHV

Equine herpesvirus 1 and 4 vaccine (Rhino)

Description

PDF Product Sheet EQUIP EHV

Composition                           

Per 1.5ml dose

Inactivated EHV type 1, strain 438/77 > 107.3 TCID50
Inactivated EHV type 4, strain 405/76 > 107.3 TCID50

Excipients:

Carbopol 934P                                      6 mg

Disodium hydrogen phosphate dehydrate

Sodium dihydrogen phosphate dehydrate

Phosphate buffer

Characteristics

Injection fluid against equine herpes virus types 1 and 4.

Indications

For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1. After completion of the primary vaccination course, the presence of antibodies has been demonstrated within 2 weeks and protection against virulent challenge has been demonstrated within 3 weeks. The duration of immunity is 6 months.